Thyago José Arruda Pacheco

Mr. Thyago José Arruda Pacheco

Universidade de Brasilia -UnB
+1
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MRMosar Correa Rodrigues
Mosar Correa Rodrigues
WTWellington Tavares
Wellington Tavares
TAThayna Mundim de Amorim
Thayna Mundim de Amorim
CVCamilla Lepesqueur Costa Vale
Camilla Lepesqueur Costa Vale
JAQUELINE VAZ DE OLIVEIRAJAQUELINE VAZ DE OLIVEIRA
JAQUELINE VAZ DE OLIVEIRA
Luis Alexandre MUEHLMANNLuis Alexandre MUEHLMANN
Luis Alexandre MUEHLMANN
Photodynamic therapy (PDT) has been clinically employed to treat mainly superficial cancer, such as basal cell carcinoma. This approach can eliminate tumors by direct cytotoxicity, tumor ischemia, or by triggering an immune response against tumor cells. Among the immune-related mechanisms of PDT, the induction of immunogenic cell death (ICD) in target cells is to be cited. ICD is an apoptosis modality distinguished by the emission of damage-associated molecular patterns (DAMP). Therefore, this study aimed to analyze the immunogenicity of CT26 and 4T1 treated with PDT mediated by aluminum-phthalocyanine in nanoemulsion (PDT-AlPc-NE). Different PDT-AlPc-NE protocols with varying doses of energy and AlPc concentrations were tested. The death mechanism and the emission of DAMPs–CRT, HSP70, HSP90, HMGB1, and IL-1β–were analyzed in cells treated in vitro with PDT. Then, the immunogenicity of these cells was assessed in an in vivo vaccination-challenge model with BALB/c mice. CT26 and 4T1 cells treated in vitro with PDT mediated by AlPc IC50 and a light dose of 25 J/cm2 exhibited the hallmarks of ICD, i.e., these cells died by apoptosis and exposed DAMPs. Mice injected with these IC50 PDT-treated cells showed, in comparison to the control, increased resistance to the development of tumors in a subsequent challenge with viable cells. Mice injected with 4T1 and CT26 cells treated with higher or lower concentrations of photosensitizer and light doses exhibited a significantly lower resistance to tumor development than those injected with IC50 PDT-treated cells. The results presented in this study suggest that both the photosensitizer concentration and light dose affect the immunogenicity of the PDT-treated cells. This event can affect the therapy outcomes in vivo.

14 May 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Danielle Galdino De SouzaDanielle Galdino De Souza
Danielle Galdino De Souza
DSDébora Silva Santos
Débora Silva Santos
KSKarina Smidt Simon
Karina Smidt Simon
JMJosé Athayde Vasconcelos Morais
José Athayde Vasconcelos Morais
LCLuísa Coutinho Coutinho Coelho
Luísa Coutinho Coutinho Coelho
João Paulo Figueiró LongoJoão Paulo Figueiró Longo
João Paulo Figueiró Longo
Diets rich in omega-3 or -6 fatty acids will produce different profiles for cell membranes phospholipid constitutions. Omegas 3 and 6 are part of the diet and can modulate the inflammatory profile. We evaluated the effects of the oral absorption of fish oil, when associated with a lipid nanoemulsion in an experimental pulmonary inflammatory model. Pulmonary fibrosis is a disease associated with excessive extracellular matrix deposition. We determined to investigate the morphophysiological mechanisms in mice that were pretreated after induction with bleomycin (BLM). The pretreatment was for 21 days with saline solution, sunflower oil (SO), fish oil (FO), and fish oil nanoemulsion (NEW3). The animals received a daily dose of 50 mg/Kg of docosahexaenoic acid DHA and 10 mg/Kg eicosapentaenoic (EPA) (100 mg/Kg), represented by a daily dose of 40 µL of NEW3. The blank group was treated with the same amount daily (40 µL) during the 21 days of pretreatment. The animals were treated with SO and FO, 100 mg/Kg (containing 58 mg/Kg of polyunsaturated fats/higher% linoleic acid) and 100 mg/Kg (50 mg/Kg of DHA and 10 mg/Kg EPA), respectively. A single dose of 5 mg/mL (50 μL) bleomycin sulfate, by the intratracheal surgical method in BALB/cAnNTac (BALB/c). NEW3 significantly reduced fibrotic progression, which can be evidenced by the protection from loss of body mass, increase in respiratory incursions per minute, decreased spacing of alveolar septa, decreased severity of fibrosis, and changes in the respiratory system. NEW3 attenuated the inflammatory changes developed in the experimental model of pulmonary fibrosis, while group SO showed a significant increase in inflammatory changes. This concluded that the presented results demonstrated that is possible to positively modulate the immune and inflamamtory response to an external agressor, by changing the nutitional intake of specific fatty acids, such as omega-3 placed in fish oil. Moreover, these benefits can be improved by the nanoencapsulation of fish oil in lipid nanoemulsions.

12 November 2020 in Nanomedicine
Verified
Journal Article
Closed access
LLLuiza Ianny de Lima
Luiza Ianny de Lima
RFRaquel Santos Faria
Raquel Santos Faria
Marina Santiago FrancoMarina Santiago Franco
Marina Santiago Franco
MRMarjorie Coimbra Roque
Marjorie Coimbra Roque
Thyago José Arruda PachecoThyago José Arruda Pacheco
Thyago José Arruda Pacheco
João Paulo Figueiró LongoJoão Paulo Figueiró Longo
João Paulo Figueiró Longo
Aim: To investigate the effect of liposomes containing the classical cytotoxic drugs paclitaxel and doxorubicin (Lipo-Pacli/Dox), against a metastatic breast cancer model. We also investigated if L...

10 December 2020 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
Thyago José Arruda PachecoThyago José Arruda Pacheco
Thyago José Arruda Pacheco
VMVictor Mello
Victor Mello
Danielle Galdino De SouzaDanielle Galdino De Souza
Danielle Galdino De Souza
A new coronavirus, identified in Wuhan, China, has spread globally, infecting millions of people and causing significant morbidity and mortality. The pandemic state, declared by the World Health Organization on March 11, 2020, transformed the world and made people adapt to social distance to control the spread of the virus. The race against time in search of therapeutic solutions has become essential, and nanotechnology may be able to make vaccines available in record time to stimulate the immunization of individuals. Since the beginning of 2020, scientists and companies are rapidly advancing to make vaccine candidates available at a different rate compared to other pandemics that have existed. This review briefly presents the pros and cons of the third generation vaccines, Moderna / NIAID and Pfizer - BioNTech, which are in phase 3 tests, based on lipid RNA nanoparticles. Great collaborative efforts are being invested so that soon the world population will receive doses of vaccines with proven efficacy and enable increased survival, since the pandemic has already caused many irreversible losses.

3 January 2020 in Journal of Health & Biological Sciences
Verified
Journal Article
Open access
PDF file
Thyago José Arruda PachecoThyago José Arruda Pacheco
Thyago José Arruda Pacheco
Danielle Galdino De SouzaDanielle Galdino De Souza
Danielle Galdino De Souza
LLLuiza Ianny De Lima
Luiza Ianny De Lima
João Paulo Figueiró LongoJoão Paulo Figueiró Longo
João Paulo Figueiró Longo
Objetivo: analisar os recentes estudos com a hidroxicloroquina no tratamento da COVID-19. Métodos: comunicação breve relatando os principais resultados com o uso da hidroxicloroquina em ensaios clínicos e o panorama mundial desses estudos. Resultados: a maioria dos ensaios clínicos no mundo é com a hidroxicloroquina, e os resultados com o seu uso são variados. Conclusão: é urgente avaliar melhor a eficácia da hidroxicloroquina no possível tratamento da COVID-19 em pacientes não severos.

30 May 2023 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
Thyago José Arruda PachecoThyago José Arruda Pacheco
Thyago José Arruda Pacheco
AVAna Cecíla Amâncio Vieira
Ana Cecíla Amâncio Vieira
LMLeandro Silva Menezes
Leandro Silva Menezes
VBVanderlene Pinto Brandão
Vanderlene Pinto Brandão
NCNathalia Beatriz Martins Costa
Nathalia Beatriz Martins Costa
Danielle Galdino De SouzaDanielle Galdino De Souza
Danielle Galdino De Souza
3D printing, also known as additive manufacturing, is a technology that has existed since the 1980s. 3D printing can be applied to health in several ways: production of didactic material in the area of health, prostheses, surgical planning and with bioprinting of organs. There are several methodologies used for 3D printing applied to health, but basically they follow the process: idealization of the model, conversion of the file into STL, then G-Code and then printing and treatment of the printed object. The printers can use plastic, biodegradable material, powders, liquid or even living cells. The objective of this study is to show in a simplified way how 3D printing can be applied to health, addressing the main concepts of 3D printing. To carry out the article, a search was made for scientific articles from 2010-2023 with the theme 3D printing applied to health. This study showed that, since the 1980s, 3D printing has improved a lot, but challenges such as costs, production time and regulatory mechanisms still need to be overcome.